DSGN
Design Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$10.12
+0.10 ▲ +1.00%
🌙 3월 13일 5:53 PM ET (한국 3/14 06:53)
$10.32
+0.20 ▲ +1.98%
| Index | RUT | P/E | - | EPS (ttm) | -1.22 | Insider Own | 44.44% | Shs Outstand | 0.06B | Perf Week | 0.7% |
| Market Cap | 0.62B | Forward P/E | - | EPS next Y | -23.22% | Insider Trans | - | Shs Float | 0.03B | Perf Month | -2.32% |
| Enterprise Value | 0.41B | PEG | - | EPS next Q | -0.32 | Inst Own | 47.86% | Short Float | 5.07% | Perf Quarter | 7.43% |
| Income | -0.07B | P/S | - | EPS this Y | -10.82% | Inst Trans | 3.83% | Short Ratio | 5.31 | Perf Half Y | 69.8% |
| Sales | 0.00B | P/B | 2.88 | EPS next 5Y | -19.56% | ROA | -29.15% | Short Interest | 1.74M | Perf YTD | 7.89% |
| Book/sh | 3.52 | P/C | 2.84 | EPS past 3/5Y | -2.32% -52.23% | ROE | -30.7% | 52W High | -9.16% ($11.14) | Perf Year | 114.41% |
| Cash/sh | 3.56 | P/FCF | - | Sales past 3/5Y | - | ROIC | -32.74% | 52W Low | 289.23% ($2.60) | Perf 3Y | 43.55% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -39.08% | Gross Margin | - | Volatility(W/M) | 6.78% 5.34% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.58 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 17.14 | EPS Q/Q | -13.12% | Profit Margin | - | RSI (14) | 49.34 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 17.14 | Sales Q/Q | - | SMA20 | -1.22% ($10.24) | Beta | 1.63 | Target Price | $14.6 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 3000000 | SMA50 | 1.15% ($10) | Rel Volume | 1.03 | Prev Close | $10.02 |
| Employees | 124 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 23.73% - | SMA200 | 44.4% ($7.01) | Avg Volume(3M) | 0.33M | Price | $10.12 |
| IPO | 2021/3/26 | Option/Short | Yes/Yes | Trades | 2153 | Volume | 337,829 | Change | 1% |
뉴스 로딩 중...